Allergic contact dermatitis to shoes induced by dimethylfumarate: A new allergen imported from China
- Author(s): Santiago, Felicidade;
- Andrade, Pedro;
- Gonçalo, Margarida;
- Mascarenhas, Rosa;
- Figueiredo, Américo
- et al.
Published Web Locationhttps://doi.org/10.5070/D31n56g6cf
Allergic contact dermatitis to shoes induced by dimethylfumarate: A new allergen imported from China1. Dermatology Department, Hospitais da Universidade de Coimbra, Coimbra, Portugal. firstname.lastname@example.org
Felicidade Santiago1, Pedro Andrade1, Margarida Gonçalo1, Rosa Mascarenhas2, Américo Figueiredo1
Dermatology Online Journal 16 (3): 3
2. Dermatology Department, Hospital Distrital da Figueira da Foz, Portugal
Background: In the last two years several cases of severe contact dermatitis related to newly acquired sofas and armchairs originating from China have been published. The responsible allergen is dimethylfumarate (DMF), an extremely potent sensitizer and irritant found in sachets inside the furniture. Recently, cases of contact dermatitis related to shoes and riding helmets have also been described. Methods: We evaluated two patients with allergic contact dermatitis related to shoes manufactured in China that were contaminated by dimethylfumarate found in sachets placed inside the shoeboxes. Results: Patch tests with DMF extracted from the sachets inside the shoeboxes showed positive reactions. Postitive reactions were also obtained using small fragments of the shoes and tissue of the “MouldProof” sachet. The patients were instructed to avoid the suspected shoes and were treated with topical corticosteroids. Conclusions: Contact dermatitis induced by dimethylfumarate should be suspected in appropriate cases. It is important to remember that this allergen is not included in most series for patch testing.
In 2007 and 2008 a “small epidemic” emerged in the North of Europe and England. Susitaival  and Rantanen  illustrated severe cases of contact dermatitis of the back and buttocks that were related to newly acquired sofas and armchairs originating from China. Later, a relationship was established with dimethylfumarate (DMF) after the isolation by chromatography of this allergen placed in sachets inside furniture. Subsequently, this was confirmed by epicutaneous tests when these patients reacted positively to DMF [1, 2, 3, 4, 5].
Dimethylfumarate is an ester of fumaric acid that is usually commercially available as a crystalline powder or white granules. The chemical is placed in sachets inside furniture or clothes, as well in shoeboxes, which evaporates and impregnates the products, protecting them from mold. It also prevents deterioration during storage and shipping in warm and humid climates [2, 6, 9, 12].
We describe two cases of allergic contact dermatitis that was induced by DMF presence in shoes and summarize the available information concerning this new allergen.
In April and May 2009 we studied two female patients at our Allergology Unit.
The first patient, a 19-year-old massage therapist, presented with a bilateral acute dermatitis localized to the dorsal aspects of the feet and ankles, in the area of contact with a new pair of boots. Lesions appeared on the third occasion that she wore the boots and presented with an intense burning sensation and itching. She was treated with potent topical steroids; when she stopped wearing the boots the lesions slowly regressed with desquamation.
|Figure 1||Figure 2|
Three weeks later at the time epicutaneous tests were performed, a well-circumscribed dermatitis was present on the dorsal feet (Figure 1). She had bought the leather boots in a non-Chinese shop and they were kept within their shoebox that still contained two types of sachets, 3 designated “Silica gel” and 5 others designated “MouldProof” (Figure 2). The latter contained a variable amount of a white powder that corresponded to the descriptions of what we supposed to be DMF.
The second patient, a 44-year-old employee in a textile fabrication plant, reported to the emergency department with an acute inflammatory dermatitis on both feet thought to be associated with recently acquired plastic shoes that were bought in a Chinese shop. She could not remember if the shoes were in a box when she bought them.
Although she was treated with systemic and topical steroids, but within 3-4 weeks, she presented with fissured, erythematous-exudative, and pruriginous lesions, predominantly on the toes and adjacent dorsum of the feet, sparing the interdigital spaces and soles. (Figure 3)
Both patients had no previous history of atopy, contact allergy, or other skin diseases.
Methods: Epicutaneous Tests
Epicutaneous tests were applied on the upper back using Finn™ Chambers on Scanpor tape® (Epitest Ltd Oy) during 2 days using allergens from Chemotechnique™ (Malmö, Sweden) or Bial-Aristegui™ (Oporto, Portugal). Readings were done on day2 (D2) and day3 (D3) according to ICDRGC guidelines.
Patients were tested with the European baseline series (with additions from the Portuguese Contact Dermatitis Study Group) and a shoe series, including chromate, plastic, rubber allergens, glue allergens, some preservatives, and textile dyes.
The white powder extracted from “MouldProof” sachets (presumed to be DMF) was individually prepared at 0.1 percent petrolatum (pet.) in the first patient and also at 0.001 percent in the second patient. Fragments of shoes were tested “as is,” moistened with 0.9 percent saline in both patients. Small fragments of the external tissue of the “MouldProof” sachets were also tested “as is” in the first patient.
In the first patient at D2 and D3, positive patch tests were exclusively seen with DMF at 0.1 percent pet. (+++); boot fragment (+) and sachet fragment (+) (Figure 4).
The second patient, at D2 and D3, had exuberant positive results with DMF at 0.1 percent pet. (+++, with an extensive area of eczema on her back) and a bullous reaction to the shoe fragment (+++) (Figures 5 and 6). A month later, testing with a dilution of 0.001 percent of DMF still induced a ++ reaction. This patient also reacted to nickel (+), diazolidinylurea (++) and perfume mix I (+).
|Figure 5||Figure 6|
In both patients the shoe series was negative.
The patients were instructed to avoid the suspect shoes and a total resolution of the lesions was seen in a few weeks.
Topic application of fumaric acid derivatives causes important adverse effects such as irritation, rash, and non-immunologic contact urticaria [10, 15, 16]. Dimethylfumarate was the derivate that presented more irritant properties and was also classified as a moderate contact sensitizer in animal models . Its commercialization as a topical drug was not possible, mainly due to its sensitizing properties. However, fumaric acid esters mainly composed of DMF (Fumaderm®) are being prescribed systemically in Germany .
Because of the high risk of irritant reactions and active sensitization, some authors recommend that DMF should be tested at low concentrations [2, 6]. In the Rantanen  report, the 3 patients tested had positive reactions to DMF in aqueous solution at 0.01 percent to 0.001 percent (including one patient with positive reactions down to 0.0001%). Our second patient also reacted to a similar concentration of the “white powder,” presumed to be DMF, in similarly low concentrations. So, Rantanen  recommended concentrations of 0.003 percent or 0.005 percent as an upper limit. Another report  described a patient with a lichenoid dermatitis localized at the left shoulder with positive tests to fumarate (Fumaderm®) 10 percent pet.; this patient showed an intense reaction (+++). However, it is agreed that more studies are necessary to ascertain the proper concentration of DMF to be used in epicutaneous tests [2, 6].
Similarly to our findings, other investigators have reported positive epicutaneous tests with samples of tissues contaminated by DMF [2, 4, 7], as well as fragments of the sachets called “Mouldproof” . We have not studied the sachets named “Silica gel,” but Lamas et al.  warned that many sachets named “Silica gel” contain also significant amounts of DMF.
Since 1998, DMF is not legally available for use in industry. However, there are manufactures outside the European Union that can use this non-authorized biocide and export their products (Directive 98/8/EC). In March of 2009 the European Commission published a communication  that banned importation of products contaminated with DMF such as sofas, shoes, and toys (maximum limit of 0.1 mg/Kg). They proposed that contaminated products in the marketplace should be seized; consumers should be informed of the risks.
Rapid Alert System For Dangerous Consumer Products (RAPEX) is an instrument of the European Commission that has proven to be useful in reporting new cases of irritant or allergic contact dermatitis associated with DMF .
The knowledge of this newly described contact dermatitis, as well as the responsible cause is essential in clinical practice, as DMF is not included in most series for patch testing.
References1. Susitaival P, Bruze M, Zimerson E, Lammintausta K, Hasan T, Tuomiranta M, Windhoven S. An epidemic of furniture related dermatitis – the power of networking. Contact Dermatitis. 2008 May;58(Suppl.1):45.
2. Rantanen T. The cause of the Chinese sofa/chair dermatitis epidemic is likely to be contact allergy to dimethylfumarate a novel potent contact sensitizer. Br J Dermatol. 2008 Jul;159(1):218-21. [PubMed]
3. Williams JDL, Coulson LH, Susitaibal P, Winhoben SM. An outbreak of furniture dermatitis in the U.K.. Br J Dermatol. 2008 Jul;159(1):233-4. [PubMed]
4. Imbert E, Chamaillard M, Kostrzewa E, Doutre MS, Milpied B, Beylot-Barry M, Le Coz CJ, Fritsch C, Chantecler ML, Vigan M. Chinese chair dermatitis: a new form of contact dermatitis. Ann Dermatol Venereol. 2008 Nov;135(11):777-9. [PubMed]
5. Foulds I. An investigation of the cause of sofa dermatitis, results and the discovery of a new sensitizer. Contact Dermatitis. 2008 May;58(Suppl.1):40.
6. Mercader P, Serra-Baldrich E, Alomar A. Contact dermatitis to dimethylfumarate in armchairs. Allergy. 2009 May;64(5):818-9. [PubMed]
7. Guillet G, Coindre M, Levillain P, Guillet MH. Lichenoid dermatitis resulting from sensitization to dimethylfumarate: atypical presentation of "Chinese sofa dermatitis". Ann Dermatol Venereol. 2009 Mar;136(3):279-81. [PubMed]
8. Vigan M, Biver C, Bourrain JL, Pelletier F, Girardin P, Aubin F, Humbert P. Acute dimethylfumarate-induced eczema on the foot. Ann Dermatol Venereol. 2009 Mar;136(3):281-3. [PubMed]
9. Matía Cubillo AC, Emilio Huertes García JJ, De Juana Izquierdo FJ. Allergic contact dermatitis due to shoes with dimethylfumarate. Med Clin (Barc) 2009 Jun 9. [PubMed]
10. Giménez-Arnau A, Silvestre JF, Mercader P, De La Cuadra J, Ballester I, Gallardo F, Pujol M, Zimerson E, Bruze M. Shoe contact dermatitis from dimethylfumarate: clinical manifestations, patch test results, chemical analysis, and source of exposure. Contact Dermatitis. 2009 Nov;61(5):249-60. [PubMed]
11. Bruze Magnus: The Sofa Dermatitis Saga. Book of Abstracts of 10th International Congress of Dermatology 2009:636.
12. Lamas JP, Sanchez-Prado L, Garcia-Jares C, Llompart M. Determination of dimethyl fumarate in desiccant and mouldproof agents using ultrasound-assisted extraction gas chromatography with electron-capture detection. J Chromatogr A. 2009 Jul 24;1216(30):5755-8. [PubMed]
13. Rostami Yazdi M, Mrowietz U. Fumaric acid esters. Clin Dermatol. 2008 Sep-Oct;26(5):522-6. [PubMed]
14. Linker RA, Lee DH, Stangel M, Gold R. Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies. Expert Rev Neurother. 2008 Nov;8(11):1683-90. [PubMed]
15. de Haan P, von Blomberg-van der Flier BM, de Groot J, Nieboer C, Bruynzeel DP. The risk of sensibilization and contact urticaria upon topical application of fumaric acid derivatives. Dermatology. 1994;188(2):126-30. [PubMed]
16. Dücker P, Pfeiff B: Two cases of side effects of a fumaric acid ester--local therapy. Z Hautkr. 1990 Aug;65(8):734-6. [PubMed]
17. Commission Decision of 17 March 2009 requiring Member States to ensure that products containing the biocide dimethylfumarate are not placed or made available on the market. Official Journal of the European Union 2009 March;52:32-4.
© 2010 Dermatology Online Journal